Statutes, codes, and regulations
Code of Federal Regulations
Title 21 - FOOD AND DRUGSChapter I - FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICESSubchapter D - DRUGS FOR HUMAN USEPart 314 - APPLICATIONS FOR FDA APPROVAL TO MARKET A NEW DRUG
Subpart D - FDA ACTION ON APPLICATIONS AND ABBREVIATED APPLICATIONS
Section 314.170 - Adulteration and misbranding of an approved drug

21 C.F.R. § 314.170

Download
PDF
Current through November 30, 2024
Section 314.170 - Adulteration and misbranding of an approved drug

All drugs, including those the Food and Drug Administration approves under section 505 of the act and this part, are subject to the adulteration and misbranding provisions in sections 501, 502, and 503 of the act. FDA is authorized to regulate approved new drugs by regulations issued through informal rulemaking under sections 501, 502, and 503 of the act.

21 C.F.R. §314.170

50 FR 7493, Feb. 22, 1985. Redesignated at 57 FR 17983, Apr. 28, 1992, and amended at 64 FR 402, Jan. 5, 1999